LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY
- DOI
- 10.1016/j.htct.2022.09.1250
- Published
- 2022-10
- Container
- Hematology, Transfusion and Cell Therapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.htct.2022.09.1250,
title = {LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY},
author = {Özgür Pektaş and Marie Scully and Javier de la Rubia and Katerina Pavenski and Ara Metjian and Paul Knöbl and Flora Peyvandi and Spero Cataland and Paul Coppo and Johanna A. Kremer Hovinga and Jessica Minkue Mi Edou and Rui de Passos Sousa and Sriya Gunawardena and Julie Lin},
year = {2022},
journal = {Hematology, Transfusion and Cell Therapy},
doi = {10.1016/j.htct.2022.09.1250},
url = {https://doi.org/10.1016/j.htct.2022.09.1250}
}RIS
TY - JOUR TI - LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY AU - Özgür Pektaş AU - Marie Scully AU - Javier de la Rubia AU - Katerina Pavenski AU - Ara Metjian AU - Paul Knöbl AU - Flora Peyvandi AU - Spero Cataland AU - Paul Coppo AU - Johanna A. Kremer Hovinga AU - Jessica Minkue Mi Edou AU - Rui de Passos Sousa AU - Sriya Gunawardena AU - Julie Lin PY - 2022 JO - Hematology, Transfusion and Cell Therapy DO - 10.1016/j.htct.2022.09.1250 UR - https://doi.org/10.1016/j.htct.2022.09.1250 ER -
APA
Pektaş, Ö., Scully, M., Rubia, J. D. L., Pavenski, K., Metjian, A., Knöbl, P., Peyvandi, F., Cataland, S., Coppo, P., Hovinga, J. A. K., Edou, J. M. M., Sousa, R. D. P., Gunawardena, S., & Lin, J. (2022). LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY. Hematology, Transfusion and Cell Therapy. https://doi.org/10.1016/j.htct.2022.09.1250
Source records
- crossref · retrieved 2026-09-26T20:47:10.215Z